Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 3.48881 | 57 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 3.40579 | 56 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 3.42964 | 56 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 3.2631 | 54 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 3.47921 | 59 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 3.61008 | 59 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 3.4368 | 54 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 3.39895 | 56 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 3.25939 | 52 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 3.40984 | 56 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 3.40665 | 56 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 3.39324 | 56 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 3.45888 | 57 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 3.41179 | 56 |